1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-50.45%
Both companies show declining cash positions (-50.45% vs CRON.TO's -25.37%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
-53.06%
Both CRON.TO and the company show zero Short-Term Investments Growth.
-51.61%
Cash + STI yoy ≥ 1.5x CRON.TO's -25.37%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
-85.62%
Receivables growth less than half of CRON.TO's 76.60%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
86.58%
Inventory growth below half of CRON.TO's -5.36%. David Dodd would check if that's due to efficiency or supply constraints.
1463.64%
Other current assets growth < half of CRON.TO's -100.58%. David Dodd sees a leaner approach to short-term items.
-30.95%
Similar yoy growth to CRON.TO's -28.22%. Walter Schloss notes comparable short-term expansions. Investigate quality of these assets.
26.99%
Similar yoy growth to CRON.TO's 27.79%. Walter Schloss sees parallel capital spending strategies. Check utilization rates.
259.88%
Less than half of CRON.TO's -5.14%. David Dodd might see less intangible risk, assuming stable revenue growth.
140.07%
Less than half of CRON.TO's -6.07%. David Dodd sees relatively fewer intangible expansions. Possibly more tangible-driven.
212.71%
Less than half of CRON.TO's -5.94%. David Dodd sees fewer intangible expansions vs. competitor. Possibly safer balance sheet.
-41.79%
≥ 1.5x CRON.TO's -21.41%. David Dodd sees an aggressive push into LT investments. Confirm risk management.
No Data
No Data available this quarter, please select a different quarter.
8.22%
Less than half of CRON.TO's 146.23%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
92.74%
≥ 1.5x CRON.TO's 25.26%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
52.33%
≥ 1.5x CRON.TO's 5.65%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
38.80%
50-75% of CRON.TO's 52.53%. Bruce Berkowitz notes the company is paying suppliers faster or not stretching terms as competitor does.
-68.19%
Less than half of CRON.TO's 266.02%. David Dodd sees much smaller short-term leverage burden vs. competitor.
30.59%
Higher Tax Payables Growth compared to CRON.TO's zero value, indicating worse performance.
-37.01%
Below half of CRON.TO's 100.00%. Michael Burry suspects a big gap in pre-sales traction.
-50.08%
Less than half of CRON.TO's 728.99%. David Dodd sees fewer expansions in other current obligations.
-2.63%
Less than half of CRON.TO's 352.87%. David Dodd sees a more disciplined short-term liability approach.
-6.72%
Higher Long-Term Debt Growth compared to CRON.TO's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
145.63%
Less than half of CRON.TO's -33.93%. David Dodd sees fewer additions to deferred tax liabilities vs. competitor.
-11.27%
Higher Other Non-Current Liabilities Growth compared to CRON.TO's zero value, indicating worse performance.
49.36%
1.1-1.25x CRON.TO's 42.36%. Bill Ackman questions if the firm is outpacing competitor in long-term leverage.
No Data
No Data available this quarter, please select a different quarter.
28.03%
Less than half of CRON.TO's 285.19%. David Dodd sees far fewer liability expansions relative to competitor.
58.76%
Less than half of CRON.TO's -5.16%. David Dodd sees fewer share issuances vs. competitor.
-10.30%
Below half CRON.TO's -91.34%. Michael Burry suspects major net losses or high dividends vs. competitor.
0.93%
Less than half of CRON.TO's -21.16%. David Dodd sees fewer intangible or market-driven swings than competitor.
53.29%
50-75% of CRON.TO's 100.00%. Bruce Berkowitz sees fewer expansions in these equity lines.
56.66%
Below half CRON.TO's -9.61%. Michael Burry sees potential underperformance in building shareholder capital.
52.33%
≥ 1.5x CRON.TO's 5.65%. David Dodd sees faster overall balance sheet growth than competitor.
-47.68%
≥ 1.5x CRON.TO's -21.41%. David Dodd sees far stronger investment expansions than competitor.
-20.34%
Less than half of CRON.TO's 247.20%. David Dodd sees less overall debt expansion vs. competitor.
64.86%
Similar yoy changes to CRON.TO's 69.01%. Walter Schloss sees parallel net leverage strategies.
